Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS)
CNY 100.86
(0.02%)
CNY 100.86
(0.02%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 936.19 Million | 579.49 Million | 433.07 Million | 273.04 Million | 195.19 Million | 126.97 Million |
| Cost of Revenue | 266.82 Million | 88.35 Million | 68.04 Million | 43.93 Million | 27.94 Million | 23.65 Million |
| Gross Profit | 669.36 Million | 491.14 Million | 365.02 Million | 229.11 Million | 167.25 Million | 103.31 Million |
| Operating Expenses | 395.49 Million | 242.96 Million | 197.42 Million | 125.8 Million | 102.01 Million | 80.73 Million |
| Selling, General and Administrative Expenses | 281.37 Million | 130.35 Million | 108.05 Million | 67.43 Million | 60.37 Million | 56 Million |
| Research and Development Expenses | 93.64 Million | 65.96 Million | 51.91 Million | 29.99 Million | 21.67 Million | 13.81 Million |
| Other Expenses | -6 Million | 46.64 Million | 37.45 Million | 28.37 Million | 19.96 Million | -40.38 Thousand |
| Cost and Expenses | 623.72 Million | 331.31 Million | 265.46 Million | 169.74 Million | 129.95 Million | 104.38 Million |
| Operating Income | 327.45 Million | 259.26 Million | 184.99 Million | 111.25 Million | 69.65 Million | 26.75 Million |
| Interest Expense | 9.8 Million | 2.01 Million | 736.9 Thousand | 60.42 Thousand | 160.47 Thousand | 818.74 Thousand |
| Income Tax Expense | 41.61 Million | 36.84 Million | 20.01 Million | 14.91 Million | 3.89 Million | 6.4 Million |
| Earnings before Tax | 327.67 Million | 264.07 Million | 187.76 Million | 111.03 Million | 69.65 Million | 26.71 Million |
| Net Income | 303.97 Million | 232.69 Million | 171.34 Million | 96.55 Million | 66.68 Million | 20.31 Million |
| Earnings Per Share Basic | 2.89 | 2.21 | 1.63 | 0.92 | 0.63 | 0.28 |
| Earnings Per Share Diluted | 2.89 | 2.21 | 1.63 | 0.92 | 0.63 | 0.28 |
| Weighted Average Shares Outstanding | 105.25 Million | 105.17 Million | 105.13 Million | 105.13 Million | 105.13 Million | 72.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 105.25 Million | 105.17 Million | 105.13 Million | 105.13 Million | 105.13 Million | 72.53 Million |
| Gross Margin | 0.71 | 0.85 | 0.84 | 0.84 | 0.86 | 0.81 |
| EBIT Margin | 0.45 | 0.55 | 0.52 | 0.52 | 0.49 | 0.32 |
| Profit Margin | 0.32 | 0.40 | 0.40 | 0.35 | 0.34 | 0.16 |
| EBITDA | 423.87 Million | 318.52 Million | 228.18 Million | 137.7 Million | 94.04 Million | 40.79 Million |
| Earnings Before Tax Margin | 0.35 | 0.45 | 0.43 | 0.41 | 0.36 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 370.47 Million | 308.96 Million | 279.36 Million | 936.19 Million | 261.25 Million | 217.05 Million |
| Cost of Revenue | 132.06 Million | 88.12 Million | 115.46 Million | 266.82 Million | 55.01 Million | 36.58 Million |
| Gross Profit | 238.41 Million | 220.83 Million | 163.9 Million | 669.36 Million | 206.23 Million | 180.47 Million |
| Operating Expenses | 119.69 Million | 107.52 Million | 116.73 Million | 361.23 Million | 107.42 Million | 89.88 Million |
| Selling, General and Administrative Expenses | 97.37 Million | 86.51 Million | 92.4 Million | - | 113.9 Million | 38.75 Million |
| Research and Development Expenses | 22.37 Million | 21 Million | 25.66 Million | - | 23.07 Million | 21.31 Million |
| Other Expenses | 59.15 Thousand | 121 Thousand | 1.33 Million | -579.69 Thousand | 50.5 Thousand | -215.83 Thousand |
| Cost and Expenses | 251.75 Million | 195.64 Million | 232.19 Million | 628.05 Million | 162.43 Million | 126.46 Million |
| Operating Income | 118.72 Million | 113.31 Million | 47.17 Million | 308.13 Million | 98.3 Million | 92.2 Million |
| Interest Expense | 4.23 Million | 4.57 Million | 5.62 Million | 9.8 Million | 795.85 Thousand | 1.32 Million |
| Income Tax Expense | 20.7 Million | 16.67 Million | 8.04 Million | 41.61 Million | 13.33 Million | 9.79 Million |
| Earnings before Tax | 121.39 Million | 115.1 Million | 50.56 Million | 327.43 Million | 98.35 Million | 91.99 Million |
| Net Income | 105.13 Million | 102.9 Million | 52 Million | 303.97 Million | 88.78 Million | 84.78 Million |
| Earnings Per Share Basic | 0.56 | 0.98 | 0.49 | - | 0.84 | 0.81 |
| Earnings Per Share Diluted | 0.56 | 0.98 | 0.49 | - | 0.84 | 0.81 |
| Weighted Average Shares Outstanding | 189.4 Million | 105.1 Million | 105.25 Million | 105.25 Million | 105.25 Million | 105.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 189.4 Million | 105.1 Million | 105.25 Million | 105.25 Million | 105.75 Million | 105.25 Million |
| Gross Margin | 0.64 | 0.71 | 0.59 | 0.71 | 0.79 | 0.83 |
| EBIT Margin | 0.41 | 0.40 | 0.26 | - | 0.39 | 0.44 |
| Profit Margin | 0.28 | 0.33 | 0.19 | 0.32 | 0.34 | 0.39 |
| EBITDA | 152.76 Million | 122.59 Million | 72.72 Million | - | 102.73 Million | 95.43 Million |
| Earnings Before Tax Margin | 0.32 | 0.37 | 0.17 | 0.33 | 0.38 | 0.42 |
FQVTF
GDLNF
STRLGUA
BQST
688606
BAF